i696e736967687473o696e6f746976o636f6dz.oszar.com
Open in
urlscan Pro
172.67.220.76
Public Scan
URL:
https://i696e736967687473o696e6f746976o636f6dz.oszar.com/
Submission: On November 10 via api from US — Scanned from DE
Submission: On November 10 via api from US — Scanned from DE
Form analysis
2 forms found in the DOM//i777777o696e6f746976o636f6dz.oszar.com/search-results
<form id="siq_searchForm" action="//i777777o696e6f746976o636f6dz.oszar.com/search-results">
<input type="search" value="" name="s" class="hs-search-field__input" autocomplete="off" placeholder="What are you looking for?">
<a class="clear-input-btn">
×
</a>
<a class="submit-search-btn">
<svg id="magnifying-glass" viewBox="0 0 16.9 16.9">
<path d="M16.9,15.4l-4.7-4.7c2.2-3,1.6-7.2-1.4-9.5S3.5-0.3,1.3,2.7s-1.6,7.2,1.4,9.5c2.4,1.8,5.7,1.8,8.1,0l4.7,4.7
L16.9,15.4z M6.8,11.5C4.1,11.5,2,9.4,2,6.8S4.1,2,6.8,2s4.8,2.1,4.8,4.8S9.4,11.5,6.8,11.5z"></path>
</svg>
</a>
</form>
POST
<form action="" method="POST" style="all:unset;float:left;">
<input type="hidden" name="URL_Adresi" value="https://insights.inotiv.com/">
<select name="DNS_Adresi" onchange="this.form.submit()" style="all:unset;border:1px solid silver;border-width:0;margin:0px 0px 0px 20px;background-color:transparent;color:black;line-height:20px;text-align:left;padding:0 5px;font-size:14px;">
<option value="0" selected="true">Otomatik - 199.60.103.254</option>
<option value="11">CloudFlare DNS</option>
<option value="12">Türk Telekom DNS</option>
<option value="13">Google DNS</option>
<option value="14">Open DNS</option>
</select>
</form>
Text Content
Skip Navigation Inotiv * Solutions * By Therapeutic Area * * Cardiovascular * Gastrointestinal * Hepatic * Infectious Disease * * Inflammation and Immunology * Metabolic and Diabetic Disease * Neuroscience * Pulmonary * * Oncology * Renal * By Research Phase * * Discovery * IND-Enabling * Pre-Marketing Authorization * By Products and Services * Discovery and Translational Sciences * Disease Pharmacology (in vitro and in vivo) * Drug Metabolism and Pharmacokinetics (DMPK) (in vitro and in vivo) * Discovery Bioanalysis and Biomarkers * Cell and Molecular Biology * Predictive and Computational Toxicology * Toxicogenomics * Targeted Proteomics * Histology and Pathology * Safety Assessment * Toxicology * Exploratory Toxicology * Genetic Toxicology (GLP and Non-GLP) * Safety Pharmacology * Developmental and Reproductive Toxicology * Carcinogenicity * Pathology * Bioanalysis: Large Molecule (GLP) * Bioanalysis: Small Molecule (GLP) * Consulting * Archive * Surgical Support and Medical Device Testing * Medical Device Pathology * Research Models and Services * Models * Find Research Models * Models by Therapeutic Area * Model Sampling Program * Pricing * Research Services * Genetically Engineered Models and Services (GEMS) * Full Spectrum Health Monitoring * Custom Antibody Production Services * Biospecimen Services * Contract Breeding Services * Tumor Models and Services * Genetic Testing Services * Surgical Services * Research Model Support Services * Resources * Eusoft Labs™ (LIMS) * LabTracks™ * Teklad™ Diet, Bedding and Enrichment * Teklad Laboratory Animal Diets * Standard Natural Ingredient Diets * Custom Research Diets * Medicated Diets * Bedding and Environmental Enrichment Products * Contact Bedding * Custom-cut Paper Cage Liners * Enrichment Products * Resources * Diet FAQs * Phytoestrogen References * Shelf Life of Diets Used In Research * Ordering * Insights * Scientific Insights * Learn More * Blog * Learn More * Resources * Cell Line References * Eusoft Labs™ (LIMS) * Health Monitoring Reports * LabTracks™ * Safety Assessment Publications * Learn More * About * * Why Inotiv * Leadership * News and Events * About Cumberland * * Environmental, Social and Governance (ESG) * Regulatory Compliance * Global Code of Conduct and Ethics * Animal Welfare Statement * * Concordat on Openness * Global Reach * Company History * Investors * Careers * Contact * Visit Our Virtual Booth CLOSE × × * Home * Scientific Insights SCIENTIFIC INSIGHTS * Business area Brand / Corporate GEMS Research and Discovery Research models and services Safety Assessment Teklad * Service Animal Diets Antibody production Bedding and enrichment Bioanalysis COVID Clinical Pathology Contract breeding Cryopreservation Developmental and reproductive toxicology Diet-induced obesity Discovery and Development Disease pharmacology (in vitro and in vivo) Drug Metabolism and Pharmacokinetics Genetic testing Genetic toxicology Health monitoring Investigative Pathology Neuroscience Pathology Proteomics Rederivation (speed rederivation) Reproductive toxicology (DART) Research models Safety pharmacology Surgical services Target sufficiency Toxicology * Content Type Article Brochure Case Study Data/Fact/Tech Sheet Discovery E-book Infographic Podcast Poster Presentation Product guide Product/Sell sheet References Scientific Poster Speak to an expert Video Webinar White paper Clear Search Insights 345 results Learn more PIONEERING INVESTIGATIVE TOXICOLOGY FOR SAFER, FASTER DRUG DEVELOPMENT Inotiv's investigative toxicology expertise drives safe, effective therapies. Our advanced tools minimize development risks, maximize regulatory success, and accelerate time to market. Video Learn more IMMUNODEFICIENT MOUSE MODELS TO SUPPORT PROLONGED ENGRAFTMENT OF HUMAN NK AND TUMOR CELLS Explore how the B-NDG mouse model supports prolonged engraftment of human cells for research. Learn about its immunodeficient features and applications in tumor and stem cell studies. Watch the webinar now! Webinar Learn more TEKLAD TEK TALK WESTERN DIET VIDEO The Western diet is known for developing phenotypes such as hepatic ballooning, steatosis, increased focal lobular inflammation, and increased chemokines. Webinar Learn more DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY AND PATHOLOGY Learn how to evaluate drug effects on fertility and reproduction in a webinar by Inotiv. Discover how pathology findings inform DART and JAS for improved drug evaluation. Webinar Learn more WEBINAR—SOD1G93A RAT MODEL OF ALS Discover how the SOD1G93A rat aids ALS drug discovery. Learn about its development, motor phenotypes, and biomarkers in this webinar from Inotiv and Taconic. Webinar Learn more PROPHYLACTIC AND THERAPEUTIC BETA-HYDROXYBUTYRATE IMPROVED MOTOR DYSFUNCTION AND CORTICAL DAMAGE IN A MOUSE MODEL OF TRAUMATIC BRAIN INJURY Prophylactic and Therapeutic Beta-Hydroxybutyrate Improved Motor Dysfunction and Cortical Damage in a Mouse Model of Traumatic Brain Injury Scientific Poster Learn more A TRANSGENIC RAT EXPRESSING THE SOD1-G93A MUTATION EXHIBITS ALS-LIKE PHENOTYPES, RENDERING IT AN EFFECTIVE TRANSLATIONAL MODEL FOR DRUG DEVELOPMENT Discover how a transgenic rat model expressing the SOD1-G93A mutation mirrors ALS-like symptoms, making it a valuable tool for drug development research. Explore the poster for insights on disease phenotypes and study design. Scientific Poster Learn more MULTIDISCIPLINARY APPROACHES OPTIMIZE CONTRACT DRUG DISCOVERY Tired of siloed drug development? Inotiv integrates pharmacology, toxicology, and pathology for a more efficient and cost-effective process. We help you understand your drug's mechanism of action & potential risks early on. Article Learn more ENHANCED DETECTION SENSITIVITY IN NONCLINICAL CARDIOVASCULAR TELEMETRY STUDIES: IMPACT OF A CHARACTERIZED FACILITY Enhanced Detection Sensitivity in Nonclinical Cardiovascular Telemetry Studies: Impact of a Characterized Facility Scientific Poster Learn more ASSESSMENT OF FACTORS IMPACTING DUPLEXSEQ LIBRARY PERFORMANCE Assessment of Factors Impacting DuplexSeq Library Performance Scientific Poster Learn more USING HIGH-RESOLUTION MASS SPECTROMETRY AND SOFTWARE AIDED METABOLITE ASSESSMENT FOR CYTOCHROME P450 REACTION PHENOTYPING OF LOW CLEARANCE SMALL MOLECULE DRUGS Using High-Resolution Mass Spectrometry and Software Aided Metabolite Assessment for Cytochrome P450 Reaction Phenotyping of Low Clearance Small Molecule Drugs Scientific Poster Learn more THINKING BEYOND CYTOCHROME P450 INACTIVATION KINETICS ENHANCED UNDERSTANDING OF THE MECHANISM OF TUCATINIB INTERACTION WITH CYP3A4 Tucatinib is effective against HER2+ breast cancer, including brain metastases. In vitro studies identified time-dependent inhibition of CYP3A4 by tucatinib, though with low inactivation efficiency. Poster highlights mechanism. Scientific Poster * « * ‹ * 1 * 2 * 3 * › * » SUBSCRIBE TO UPDATES FROM INOTIV Sign up and you’ll receive the latest updates that matter to you, delivered straight to your inbox. Subscribe now Inotiv * * Copyright © 2024 Inotiv. All Rights Reserved. * Terms of Use * Privacy Policy * Do Not Sell Or Share My Information * Accessibility Statement * Cookie Statement Envigo Toggle navigation * Products and services * Research models * Research services * Teklad diet, bedding and enrichment * Resources * Scientific insights * Blog * News * Events * About * Executive leadership * Our brand story * Vision, mission and values * Corporate social responsibility * Our use of animals * Contact * Legal * Terms of use * Privacy policy * Cookie statement * Our use of animals Please ensure Javascript is enabled for purposes of website accessibility Otomatik - 199.60.103.254 CloudFlare DNS Türk Telekom DNS Google DNS Open DNS OSZAR »